Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Harvey

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The Journal of Clinical Investigation|June 4, 2014
Abnormal B cell memory subsets dominate HIV-specific responses in infected individualsLela Kardava, Susan Moir, Naisha Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of ResponseTimothy A Yap, Justin F Gainor, Margaret K Callahan, et al.
Cell Reports|January 22, 2023
Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortiumHeather M Callaway, Kathryn M Hastie, Sharon L Schendel, et al.
Genome Biology|March 31, 2012
The transcription factor encyclopediaDimas Yusuf, Stefanie L Butland, Magdalena I Swanson, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The Journal of Clinical Investigation|June 4, 2014
Abnormal B cell memory subsets dominate HIV-specific responses in infected individualsLela Kardava, Susan Moir, Naisha Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of ResponseTimothy A Yap, Justin F Gainor, Margaret K Callahan, et al.
Cell Reports|January 22, 2023
Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortiumHeather M Callaway, Kathryn M Hastie, Sharon L Schendel, et al.
Genome Biology|March 31, 2012
The transcription factor encyclopediaDimas Yusuf, Stefanie L Butland, Magdalena I Swanson, et al.
Pageof 5